{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 2504"}, "official-title": {"#tail": "\n\t", "#text": "To address prescription opioid and heroin abuse."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140619", "#text": "June 19, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for herself and ", "#text": "Ms. Ayotte", "@name-id": "S340"}, "cosponsor": {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Donnelly", "@name-id": "S356"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t  ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " declares that many controlled substances have\n\t\t\t a useful and legitimate medical purpose and are necessary to maintain the\n\t\t\t health and general welfare of the people of the United States.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Controlled Substances Act", "@value": "Controlled Substances Act"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 801 et seq.", "@value": "usc/21/801/etseq"}, "@parsable-cite": "usc/21/801", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "id799fef2a46a2427a86e42f84bfab4e4b", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Health care professionals, medical experts, researchers, and scientists have found pain to be a\n\t\t\t major national health problem."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "ide84ffaa1c57e4bab9fc7e9959b1cb706", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "The responsible treatment of pain is a high priority for our Nation and the needs of individuals\n\t\t\t with pain must be taken into careful consideration when taking steps to\n\t\t\t prevent prescription drug misuse and abuse."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "id109fc5e6ee4f44ae815922759051e859", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "When no longer needed or wanted for legitimate pain management or health treatment, prescription\n\t\t\t opioids are susceptible to diversion.\tPrescription opioids also may be\n\t\t\t abused by individuals who were not prescribed such drugs or misused by\n\t\t\t individuals not taking such drugs as directed."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "id55c8f6d0fd3a4838b730e48454ec39f3", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Approximately 4 out of 5 new heroin users report that they became addicted to prescription\n\t\t\t opioids before they used heroin for the first time."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "idAC1353697FC94732A6D323092EEFC79B", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "According to the National Institute on Drug Abuse, heroin attaches to the same brain cell receptors\n\t\t\t as\n\t\t\t prescription opioids."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "id67F77B940F784BB596C1B4741100673B", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "The low cost and high purity of currently available heroin has contributed to an increase in heroin\n\t\t\t use."}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "idA2B9440DA7BB4084ADB474C8F9E57A2A", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "More people are using heroin, and are using heroin at a younger age.  The National Survey on Drug\n\t\t\t Use and Health  reports that new heroin users numbered 142,000 in 2010,\n\t\t\t and increased to 178,000 in 2011. In 2011, the average age at first use\n\t\t\t among heroin abusers between 12 and 49 years was 22.1 years.  In 2009, the\n\t\t\t average age at first use among\n\t\t\t heroin abusers between 12 and 49 years was 25.5 years."}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "id592a62703c16448bb8a37dd1fedd7881", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", heroin use rose 79 percent nationwide\n\t\t\t between 2007 and 2012.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "According to the "}, "enum": {"#tail": "\n        ", "#text": "(9)"}, "@id": "id1c0bc72f5a7c4897b40b36928469bf2d", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the number of\n\t\t\t deaths involving heroin increased by 110 percent from 2006 to 2011.  From\n\t\t\t 2010 to 2011, the number of heroin deaths rose from 3,036 to 4,397.", "@entity-type": "federal-body", "#text": "Centers for Disease Control and Prevention", "@entity-id": "7523"}, "#text": "Deaths from heroin overdose have significantly increased in communities across the United States.\n\t\t\t According to the "}, "enum": {"#tail": "\n        ", "#text": "(10)"}, "@id": "id9A94221687424F399A4199F92B03452E", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "The Edward Byrne Memorial Justice Assistance Grant\nProgram is critical to fighting the prescription opioid abuse and heroin use epidemics, and should\n\t\t\t be reauthorized and fully funded."}, "enum": {"#tail": "\n        ", "#text": "(11)"}, "@id": "idF0072C9261094FD7B7B831F1D0143FAE", "#text": "\n        "}], "#text": "\n      ", "@id": "idF6B336CB85B04080B063F639674E03DA"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Development of best prescribing practices"}, "subsection": [{"#tail": "\n      ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (referred to in this section as the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t Services", "@entity-id": "7500"}, {"#tail": ", the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary of Veterans Affairs", "@entity-id": "3600"}, {"#tail": ", and the ", "@entity-type": "federal-body", "#text": "Secretary of Defense", "@entity-id": "9700"}, {"#tail": ", shall convene a ", "@entity-type": "federal-body", "#text": "Administrator of the Drug\n\t\t\t Enforcement Administration", "@entity-id": "1524"}, {"#tail": " (referred to in this section as the ", "@entity-type": "federal-body", "#text": "Pain Management Best Practices\n\t\t\t Inter-Agency Task Force", "@value": "Pain Management Best Practices Inter-Agency Task Force", "@proposed": "true"}], "term": {"#tail": ").", "#text": "task force"}, "#tail": "\n      ", "quote": {"#tail": "), in cooperation with the ", "#text": "Secretary"}, "@display-inline": "yes-display-inline", "#text": "Not later than 120 days after the date of enactment of this Act, the "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Inter-Agency task force"}, "#text": "\n        ", "@id": "id1DB8AFA1D8EB4E3FB7F3F4C07FD763F1"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "The task force shall be comprised of\u2014"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Membership"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "representatives of\u2014"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "id26472ABD42EA4D1EA92911C6A359D96D", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "the "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "idB92DAA83988147E08DA7869510C0A065", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Department of Veterans Affairs", "@entity-id": "3600"}, "#text": "the "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "idD9EE5706BC0948EC835491614323E366", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Department of Defense", "@entity-id": "9700"}, "#text": "the "}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "id83B4D7D6772648508EEF809674D4AC23", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "federal-body", "#text": "Drug Enforcement Administration", "@entity-id": "1524"}, "#text": "the "}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "idA277E7D498D248718F8F75B1F4CEB69F", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "the Institute of Medicine;"}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "@id": "idBFEF9A28F13D42F68BA65D119DFE116B", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Director of the National Institutes of Health", "@entity-id": "7529"}, "#text": "the "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "id31C83658DEAB406DBDF8EABCCCE7F9E8", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "physicians and non-physician prescribers;"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "idE5F1D75ED2ED4D97B79842416AAC6598", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "pharmacists;"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "idC91040E17127454FAA8018D21396CD99", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "experts in the fields of pain research and addiction research;"}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "idFE7DF4AB1EC345C8A275FFC522BA74AD", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "representatives of\u2014"}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "#text": "\n          ", "@id": "id8373C06495824232B90DEAFA3AACF416", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "pain management professional organizations;"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "idD2B358B00ABE4110A2BE502289053EC5", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "the mental health treatment community; and"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "id495CE2AEACFE4958B376EB188E4002AA", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "pain advocacy groups; and"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "id3FFB34330E07449AB034B181A1E42D40", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "other stakeholders, as the "}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "@id": "idB6E8806FC1144FF6A2326E7FC0C3DCB3", "#text": "\n          "}], "#text": "\n        ", "@id": "id6B3CE7B30AA24734819E750690110416"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "The task force shall\u2014"}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Duties"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "not later than 180 days after the date on which the task force is convened, develop best practices\n\t\t\t for pain management and prescription pain medication prescribing\n\t\t\t practices, taking into consideration\u2014"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "idA63C2D62ECCF42E0A3D2208182FCA399", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "existing pain management research;"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "idF1671EBB2DC34F559800DBF00184C3B3", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "recommendations from relevant conferences; and"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "idF384E1FAC748471093FB63C352B5F1E1", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "ongoing efforts at the State and local levels and by medical professional organizations to develop\n\t\t\t improved pain management strategies;"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "id586A3DB0075D40B78C2D22D483C132CD", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t amending such best practices if appropriate; and", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:1", "@proposed": "true"}, "#text": "solicit and take into consideration public comment on the practices developed under "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "id4C8EAA26346447E184C59CD6430F22E3", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (1)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:1", "@proposed": "true"}, {"#tail": " to prescribers,\n\t\t\t pharmacists, State medical boards, and other \n\t\t\t parties, as the ", "@entity-type": "act", "#text": "(2)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:2", "@proposed": "true"}, {"#tail": " determines appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "develop a strategy for disseminating information about the\n\t\t\t best practices developed under "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "id6BB44B36954248D0BD00D7573EA7F90E", "#text": "\n          "}], "#text": "\n        ", "@id": "idA8748354C25D4BFBA724B3CD1B9D15B8"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "The task force shall not have rulemaking authority."}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Limitation"}, "#text": "\n        ", "@id": "id4DF15AEE8B30460FA2E9A3E1BB68CDC8", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t the task force shall submit to\n\t\t\t ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:a", "@proposed": "true"}, {"#tail": " a report that includes\u2014", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than 270 days after the date on which the task force is convened under "}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Report"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (c)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c", "@proposed": "true"}, "#text": "the strategy for disseminating best practices developed under "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "id7C7932BB92E54C75A122015A20C67DAC", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (1)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:1", "@proposed": "true"}, {"#tail": " to receiving and\n\t\t\t renewing registrations under ", "@entity-type": "act", "#text": "(2) of\n\t\t\t subsection (c)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:3/ss:c/p:2", "@proposed": "true"}], "#text": "the results of a feasibility study on\n\t\t\t linking best practices developed under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 303(f) of the Controlled Substances\n\t\t\t Act", "@value": "Controlled Substances Act/s:303/ss:f"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 823(f)", "@value": "usc/21/823/f"}, "@parsable-cite": "usc/21/823", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "id8B85523F3FC84731B7F67F3059E4422D", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Veterans Health Administration", "@entity-id": "3620"}, "#text": "recommendations on how to apply such best practices to improve prescribing practices at medical\n\t\t\t facilities of the "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "id0BC207E8D025487791A31D46E34EE7A8", "#text": "\n          "}], "#text": "\n        ", "@id": "idA819166BC4C3401C961913A61896E8CC"}], "#text": "\n      ", "@id": "id061F0FCB23FE4B6C82D290D269FA4E95"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Harold Rogers Prescription Drug Monitoring Program"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "$9,000,000 for each of fiscal years\n\t\t\t 2015 through 2019", "@amount": "9000000", "@year": "2015, 2016, 2017, 2018, 2019"}, "@entity-type": "auth-auth-approp", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}property": {"#tail": ",\n\t\t\t there is authorized to be appropriated ", "#text": "To carry out the Harold Rogers Prescription Drug Monitoring Program established under the\n\t\t\t ", "@name": "purpose", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Departments of Commerce, Justice, and State, the Judiciary, and Related\n\t\t\t Agencies Appropriations Act, 2002", "@value": "Departments of Commerce, Justice, and State, the Judiciary, and Related Agencies Appropriations Act, 2002"}, {"#tail": ")", "@entity-type": "statute-at-large", "#text": "115 Stat. 748", "@value": "statute-at-large/115/748"}], "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": "; ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "public-law", "#text": "Public Law 107\u201377", "@value": "public-law/107/77"}, "@parsable-cite": "pl/107/77", "#text": "\n            ", "@legal-doc": "public-law"}}}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Authorization of appropriations"}, "#text": "\n        ", "@id": "id550A8DC025DD4BCC81BA8DFA45D0CFF7"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to\n\t\t\t ", "@entity-type": "federal-body", "#text": "Comptroller General of the United States", "@entity-id": "0500"}, {"#tail": " a report on the effectiveness\n\t\t\t of the Harold Rogers Prescription Drug Monitoring Program in reducing\n\t\t\t prescription drug abuse, and, to the extent practicable, any corresponding\n\t\t\t increase or decrease in the use of heroin.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than October 1, 2016, the "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "GAO report"}, "#text": "\n        ", "@id": "id2DBABFDCA9DA4B8DBDC6EE0159450C2C"}], "#text": "\n      ", "@id": "id58BC7B63D4F545FCAFD24D376F9C3B6B"}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "quote": [{"#tail": " and inserting ", "#text": "2006 through 2012"}, {"#tail": ".", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "@entity-type": "auth-auth-approp", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": "\n          ", "#text": "2015 through 2019", "@amount": "1095000000", "@year": "2015, 2016, 2017, 2018, 2019"}}}], "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t is amended by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 508 of title I of the Omnibus Crime Control and Safe Streets Act of 1968", "@value": "Omnibus Crime Control and Safe Streets Act of 1968/t:I/s:508"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "42 U.S.C. 3758", "@value": "usc/42/3758"}, "@parsable-cite": "usc/42/3758", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "Reauthorization of Byrne Justice Assistance Grant program"}, "#text": "\n      ", "@id": "id9745378078C6422B97641CCE69F63BE1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "Office of National Drug Control Policy"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall revise the 2011 Prescription Drug Abuse\n\t\t\t Prevention Plan to  reassess the approach under such plan to addressing\n\t\t\t prescription drug abuse in light of an increase in heroin use, and to\n\t\t\t outline actions or programs that can be carried out to reduce and prevent\n\t\t\t such abuse.", "@entity-type": "federal-body", "#text": "Director of the Office of\n\t\t\t National Drug Control Policy", "@entity-id": "1127"}, "#text": "Not later than 180 days after the date of enactment of this Act, the "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Update of plan To account for increased heroin use"}, "#text": "\n        ", "@id": "id0027F24AE1A54058AC3C203DC82F6B83"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall ensure that the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1127"}, {"#tail": " takes into account the\n\t\t\t report of the ", "@entity-type": "federal-body", "#text": "Office of National Drug Control Policy", "@entity-id": "1127"}, {"#tail": " entitled ", "@entity-type": "federal-body", "#text": "Government Accountability Office", "@entity-id": "0500"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:6/ss:a", "@proposed": "true"}], "#text": "The ", "quote": {"#tail": " issued on March 26, 2013 (GAO\u201313\u2013333), and identifies opportunities to enhance interagency\n\t\t\t coordination as part of the Prescription Drug Abuse Prevention Plan, as\n\t\t\t revised under ", "#text": "\n            Office of National Drug Control Policy: Office Could Better Identify Opportunities to Increase\n\t\t\t Program Coordination"}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "GAO recommendations for inter-Agency coordination"}, "#text": "\n        ", "@id": "id2AC0C629764F49CBA6F35ABA72B008C3"}], "#text": "\n      ", "@id": "id3042ED40E3F24AD4B83078638A480654"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n      ", "#text": "Awareness campaigns"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall advance the education and awareness of providers,\n\t\t\t patients, and other appropriate\n\t\t\t stakeholders regarding the risk of abuse of prescription opioid drugs if\n\t\t\t such products are not taken as prescribed.", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "#text": "\n        ", "@id": "id4C1E64C2396C4CAD9F33557113A79D05"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Drug-Free media campaign"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in coordination with the ", "@entity-type": "federal-body", "#text": "Office of National Drug Control Policy", "@entity-id": "1127"}, {"#tail": " and the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t Services", "@entity-id": "7500"}, {"#tail": ", shall establish\n\t\t\t a national drug awareness campaign.", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In general"}, "#text": "\n          ", "@id": "id47593B522A1D4334B7D2B979FE2479C7"}, {"#tail": "\n        ", "@id": "id0BFCA3031F1C4715B5FA930CD63A61BD", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Requirements"}, "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014/s:7/ss:b/p:1", "@proposed": "true"}, "#text": "The national drug awareness campaign under "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "take into account the association between\n\t\t\t prescription opioid abuse and heroin use; and"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "idF87FA1104C16474ABE60C5DB791D9543", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "emphasize\n\t\t\t the similarities between heroin and prescription opioids and the effects\n\t\t\t of heroin and prescription opioids on the human body."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "idCCBC496B7025480CB1D6A1C8846C0F0A", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and otherwise available for\n\t\t\t obligation and expenditure.", "@entity-type": "federal-body", "#text": "Office of National Drug Control Policy", "@entity-id": "1127"}, "#text": "Funds for the national drug awareness campaign may be derived from amounts appropriated to the\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Available funds"}, "#text": "\n          ", "@id": "id4E38F110590541698261E06A2FCB2467"}], "#text": "\n        ", "@id": "id17F73FBF54514F19ACADE0D2BA465150"}], "#text": "\n      ", "@id": "id0775A4C1907C4406AF5C114CEA467EF3"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-06-19"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2504 IS: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}